Dietary-Induced Low-Grade Inflammation in the Liver.

control diet high fat diet liver inflammation low-grade inflammation non-alcoholic fatty liver disease

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
09 Dec 2020
Historique:
received: 19 10 2020
revised: 26 11 2020
accepted: 07 12 2020
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 16 12 2020
Statut: epublish

Résumé

The literature describes a close correlation between metabolic disorders and abnormal immune responses, like low-grade inflammation (LGI), which may be one mechanistic link between obesity and various comorbidities, including non-alcoholic fatty liver disease (NAFLD). In our study, we investigated the influence of dietary composition on obesity-derived LGI in the liver. We used a dietary induced obesity mouse model of C57BL/6J mice fed with high fat diet (HFD, 60% fat, 20% protein, 20% carbohydrates) and two different controls. One was rich in carbohydrates (10% fat, 20% protein, 70% carbohydrates), further referred to as the control diet (CD), and the other one is referred to as the standard diet (SD), with a more balanced macronutrient content (9% fat, 33% protein, 58% carbohydrates). Our results showed a significant increased NAFLD activity score in HFD compared to both controls, but livers of the CD group also differed in their macroscopic appearance from healthy livers. Hepatic fat content showed significantly elevated cholesterol concentrations in the CD group. Histologic analysis of the cellular immune response in the liver showed no difference between HFD and CD and expression analysis of immunologic mediators like interleukin (IL)-1β, IL-6, IL-10 and tumor necrosis factor alpha also point towards a pro-inflammatory response to CD, comparable to LGI in HFD. Therefore, when studying diet-induced obesity with a focus on inflammatory processes, we encourage researchers to carefully select controls and not use a control diet disproportionally rich in carbohydrates.

Identifiants

pubmed: 33317065
pii: biomedicines8120587
doi: 10.3390/biomedicines8120587
pmc: PMC7763065
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : KU 3280/1-2 and JA 2872/1-2

Références

Diabetes. 2015 Apr;64(4):1120-30
pubmed: 25315009
Cell Mol Gastroenterol Hepatol. 2017 Apr 22;4(2):223-236
pubmed: 28649594
Physiol Behav. 2004 Apr;81(2):243-8
pubmed: 15159170
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
Nature. 2017 Feb 8;542(7640):177-185
pubmed: 28179656
Obes Rev. 2012 Oct;13(10):923-84
pubmed: 22780564
Diabetes. 2010 Apr;59(4):916-25
pubmed: 20103702
J Clin Invest. 2017 Jan 3;127(1):1-4
pubmed: 28045402
J Cell Mol Med. 2019 May;23(5):3375-3385
pubmed: 30772951
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Exp Clin Endocrinol Diabetes. 2001;109(6):307-19
pubmed: 11571668
J Clin Med. 2019 May 18;8(5):
pubmed: 31109070
Cell Mol Immunol. 2016 May;13(3):267-76
pubmed: 27063467
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Acta Pharm Sin B. 2020 Jan;10(1):171-185
pubmed: 31993314
Nutrients. 2016 Oct 29;8(11):
pubmed: 27801862
Food Funct. 2019 Sep 1;10(9):6170-6183
pubmed: 31501836
Diabet Med. 2007 Jan;24(1):1-6
pubmed: 17227317
Oxid Med Cell Longev. 2018 May 31;2018:2548154
pubmed: 29955245
Diabetes. 2001 Aug;50(8):1844-50
pubmed: 11473047
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Br J Nutr. 2015 Oct 14;114(7):999-1012
pubmed: 26228057
J Clin Invest. 2003 Dec;112(12):1785-8
pubmed: 14679172
Exp Biol Med (Maywood). 2018 Jan;243(1):1-12
pubmed: 29065724
Arch Intern Med. 1989 Jul;149(7):1514-20
pubmed: 2662932
Neurology. 2012 Aug 21;79(8):755-62
pubmed: 22915175
Digestion. 2011;83(1-2):124-33
pubmed: 21042023
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):547-66
pubmed: 16311216
Eur J Nutr. 2013 Apr;52(3):1181-9
pubmed: 22847642
Gastroenterology. 2017 Feb;152(3):571-585.e8
pubmed: 27765690
Aging (Albany NY). 2015 Apr;7(4):256-68
pubmed: 25979814
World J Gastroenterol. 2014 Jul 28;20(28):9330-7
pubmed: 25071327
Eur J Endocrinol. 2020 Jan;182(1):47-56
pubmed: 31658438
PLoS One. 2012;7(10):e47713
pubmed: 23091640
Mol Cell Endocrinol. 2015 Sep 5;412:65-72
pubmed: 26033245
Ann Clin Transl Neurol. 2019 Nov;6(11):2340-2346
pubmed: 31608604
Am J Gastroenterol. 2008 Jun;103(6):1372-9
pubmed: 18510618
Curr Opin Lipidol. 2011 Dec;22(6):479-88
pubmed: 22002020
Sci Rep. 2020 Jun 17;10(1):9806
pubmed: 32555236
Clin Biochem Rev. 2004 Aug;25(3):165-81
pubmed: 18458706
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179
J Clin Invest. 2017 Jan 3;127(1):55-64
pubmed: 28045404

Auteurs

Nicole Power Guerra (N)

Rudolf-Zenker-Institute for Experimental Surgery, Medical University Rostock, 18057 Rostock, Germany.

Luisa Müller (L)

Rudolf-Zenker-Institute for Experimental Surgery, Medical University Rostock, 18057 Rostock, Germany.
Department of Psychosomatic Medicine and Psychotherapy, University of Rostock, 18147 Rostock, Germany.

Kristin Pilz (K)

Department of Psychiatry, University of Greifswald, 17489 Greifswald, Germany.

Annika Glatzel (A)

Rudolf-Zenker-Institute for Experimental Surgery, Medical University Rostock, 18057 Rostock, Germany.

Daniel Jenderny (D)

Rudolf-Zenker-Institute for Experimental Surgery, Medical University Rostock, 18057 Rostock, Germany.

Deborah Janowitz (D)

Department of Psychiatry, University of Greifswald, 17489 Greifswald, Germany.

Brigitte Vollmar (B)

Rudolf-Zenker-Institute for Experimental Surgery, Medical University Rostock, 18057 Rostock, Germany.

Angela Kuhla (A)

Rudolf-Zenker-Institute for Experimental Surgery, Medical University Rostock, 18057 Rostock, Germany.

Classifications MeSH